What happens during a prostate cancer screening

A prostate cancer screening usually involves two tests: a blood test and a physical exam. The blood test measures prostate-specific antigen (PSA), a protein the prostate makes. The physical exam is called a digital rectal exam (DRE), where a doctor inserts a gloved, lubricated finger into the rectum to feel the prostate's size and texture. Neither test diagnoses cancer — they only flag whether further testing might be needed.

The PSA test takes a few minutes and happens during a regular office visit. A nurse draws blood from your arm, and the sample goes to a lab. Results come back in days. The DRE also takes a few minutes and happens in the same visit. Both tests are uncomfortable but brief, and neither requires anesthesia or recovery time.

Screening is different from diagnosis. A screening result that seems abnormal means your doctor will likely recommend a biopsy — a procedure where a needle removes tiny pieces of prostate tissue so a pathologist can look for cancer cells under a microscope. That is the only way to confirm whether cancer is actually present.

Key Takeaways

  • PSA blood tests and digital rectal exams are the two main screening tools, but neither one diagnoses cancer on its own.
  • A biopsy — where a needle removes prostate tissue — is the only way to confirm whether cancer cells are present.
  • PSA levels vary by age, race, and individual factors, so your doctor interprets your result in context, not as a single number.
  • Screening decisions depend on your age, family history, and personal risk factors, and reasonable doctors disagree about when to start.

PSA blood test: what the numbers mean

PSA is measured in nanograms per milliliter (ng/mL). A PSA below 4 ng/mL is generally considered normal, though this threshold is not a hard cutoff — some men with cancer have PSA below 4, and some without cancer have PSA above 4. Age matters: PSA naturally rises as you get older, so a result that would be concerning in a 50-year-old might be normal in a 75-year-old.

Race also affects how doctors interpret PSA. Black men tend to have higher PSA levels on average and develop prostate cancer earlier and more aggressively than white men, so some doctors use a lower threshold (3 ng/mL instead of 4) when screening Black men. Your doctor should discuss what your specific result means for you rather than just comparing it to a single number.

A rising PSA over time can matter more than a single high result. If your PSA was 2 ng/mL last year and is now 4 ng/mL, that rapid climb might prompt further testing even though 4 is technically "normal." Conversely, a stable PSA of 5 ng/mL year after year might not trigger a biopsy. Your doctor tracks the trend, not just the snapshot.

Digital rectal exam and what doctors feel for

During a DRE, your doctor inserts a gloved finger into the rectum to reach the prostate, which sits just in front of the rectum. The prostate normally feels smooth and firm, about the size of a walnut. A doctor checking for cancer feels for lumps, hard spots, or areas where the tissue feels abnormal — thickened, asymmetrical, or nodular.

A DRE alone catches some cancers that PSA misses, especially aggressive ones that grow quickly. However, a DRE can only detect cancers in the back part of the prostate, where the doctor's finger can reach. Cancers in the front or sides might not be felt. Many doctors now offer DRE as part of screening, but some have moved away from it because PSA testing alone has become more common.

An abnormal DRE result — a lump, hardness, or asymmetry — usually leads to a biopsy, even if PSA is normal. Conversely, a normal DRE does not rule out cancer if PSA is elevated. Your doctor uses both pieces of information together to decide whether a biopsy is warranted.

Prostate biopsy: how it works and what to expect

If screening results suggest cancer might be present, your doctor will recommend a biopsy. The most common type is a transrectal ultrasound-guided biopsy (TRUS biopsy). A small ultrasound probe is inserted into the rectum to create an image of the prostate. Using that image as a guide, a spring-loaded needle fires through the rectal wall into the prostate, removing 10 to 12 tiny tissue samples in a few seconds. The whole procedure takes 10 to 15 minutes.

You will feel pressure and a sharp sensation when the needle fires, but local anesthesia numbs the area beforehand. Some men describe it as uncomfortable rather than painful. After the biopsy, you may see blood in your urine, stool, or semen for a few days — this is normal. You can usually go home the same day and return to normal activities within a day or two.

A pathologist examines the tissue samples under a microscope and assigns a Gleason score, which grades how abnormal the cancer cells look. Scores range from 6 to 10; lower scores mean the cancer looks more like normal prostate tissue and tends to grow slowly, while higher scores mean the cells look very abnormal and the cancer is likely to grow faster. The biopsy result tells you whether cancer is present, where it is, and how aggressive it appears.

Who should be screened and when to start

Screening recommendations differ depending on your age and risk factors. The American Cancer Society recommends that men at average risk discuss screening starting at age 50. Men at higher risk — those with a family history of prostate cancer, Black men, or men with a genetic mutation like BRCA1 or BRCA2 — should have that conversation starting at age 40 or 45. Men under 40 with no risk factors are not usually screened.

The decision to screen is not automatic. Your doctor should discuss the potential benefits (catching cancer early, when treatment may be more effective) and the potential harms (false positives leading to unnecessary biopsies, overdiagnosis of slow-growing cancers that would never cause harm, anxiety from abnormal results). Reasonable doctors and patients disagree about whether screening is worthwhile, especially for men over 70 or those with a life expectancy under 10 years.

If you decide to be screened, how often you get tested depends on your results and your doctor's recommendation. Men with normal PSA and DRE might be screened every year or every two years. Men with elevated PSA but negative biopsy might be monitored more closely. Your doctor will recommend a schedule based on your individual situation.

What happens if screening results are abnormal

An abnormal screening result does not mean you have cancer. Many men have elevated PSA or an abnormal DRE but no cancer on biopsy. Benign prostate enlargement, prostatitis (inflammation of the prostate), and recent ejaculation can all raise PSA. A biopsy is the only way to know for certain whether cancer is present.

If your biopsy shows no cancer, your doctor may recommend repeat screening in a few months or continued monitoring. If your biopsy shows cancer, your doctor will discuss treatment options based on the Gleason score, the stage of the cancer (how far it has spread), your age, and your overall health. Some slow-growing cancers are managed with active surveillance — regular monitoring without immediate treatment — while others are treated with surgery, radiation, or hormone therapy.

Getting an abnormal result is stressful, but it is important to remember that many abnormal results do not lead to a cancer diagnosis. Take time to understand your results, ask your doctor questions, and if you want a second opinion, ask for a referral to another urologist or oncologist.

Frequently Asked Questions

Does a high PSA always mean I have prostate cancer?

No. Many conditions raise PSA, including benign prostate enlargement, urinary tract infections, and recent ejaculation. A high PSA means your doctor should investigate further, usually with a DRE and possibly a biopsy, but it does not confirm cancer. Only a biopsy showing cancer cells confirms the diagnosis.

Is the digital rectal exam necessary if I have a PSA test?

PSA and DRE catch different things. PSA can miss some aggressive cancers, while DRE can detect cancers in the back of the prostate that PSA might not flag. Many doctors offer both as part of screening, though some now rely on PSA alone. Ask your doctor whether a DRE is part of your screening plan.

How painful is a prostate biopsy?

A biopsy is uncomfortable but usually not severely painful. Local anesthesia numbs the area, and the needle fires quickly. Most men describe pressure and a sharp sensation rather than pain. You may have mild discomfort for a day or two afterward, and blood in urine or stool is normal for a few days.

What if my biopsy is negative but my PSA keeps rising?

A negative biopsy with rising PSA can mean cancer was missed, or it can mean something else is raising your PSA. Your doctor may recommend repeat biopsy, imaging tests like an MRI, or closer monitoring with PSA checks every few months. The decision depends on how fast your PSA is rising and your overall risk factors.

At what age should I stop being screened?

Most organizations recommend stopping routine screening around age 70 or when your life expectancy is less than 10 years due to other health conditions. Screening older men is less likely to catch cancer in time to help, and the risks of biopsy and overtreatment increase. Talk with your doctor about whether screening makes sense for your age and health status.